August, 26 2026 Wednesday 01:44 Hrs
Last update 11-9-2025
  • SENSEX :   77,656.09

  • Commodity broking firm in India286.98( 0.37%) 25-Aug-2026
Positive
Sensex 77656.09 286.98  (0.37) 25-Aug-2026
Previous Day Close 77369.11
Today's High/Low
High Low
  •  
  •  
77666.39 77125.91

Profit and Loss

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
394.8213477
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
35.54
92612.83
EPS(TTM)
Face Value()
Div & Yield %
45.29
1
0.25
 
Particulars(INCOME)Mar 2026
( Cr)
Mar 2025
( Cr)
Mar 2024
( Cr)
Mar 2023
( Cr)
Mar 2022
( Cr)
Mar 2021
( Cr)
Sales Turnover 11171.7210933.3010645.648457.0011287.1415823.68
Excise Duty0.000.000.000.000.000.00
Net Sales11171.7210933.3010645.648457.0011287.1415823.68
Other Income 587.53328.12670.10443.92670.99589.86
Stock Adjustments -46.5567.66116.23263.95-45.51-2.99
Total Income11712.7011329.0811431.979164.8711912.6216410.55
EXPENDITURE :
Raw Materials 5311.585675.345964.484755.955800.747241.83
Power & Fuel Cost174.82185.59191.58167.86477.99512.34
Employee Cost 1161.151063.07980.56890.531600.041735.42
Other Manufacturing Expenses 421.52426.63414.51328.42705.68925.86
Selling & Administrative Expenses 873.42960.27822.21939.381009.361069.84
Miscellaneous Expenses 108.12132.49164.49148.96249.13215.57
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure8050.618443.398537.837231.109842.9411700.86
Operating Profit3662.092885.692894.141933.772069.684709.69
Interest 213.15230.04182.6074.5816.9428.68
Gross Profit3448.942655.652711.541859.192052.744681.01
Depreciation285.36297.20254.58243.26415.26488.00
Profit Before Tax3163.582358.452456.961615.931637.484193.01
Tax746.82627.37598.08412.16379.701043.34
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax1.96-15.71-95.26-23.34-196.9336.76
Reported Net Profit2414.801746.791954.141227.111454.713112.91
Extraordinary Items -11.939.463.289.94-81.27-0.13
Adjusted Net Profit2426.731737.331950.861217.171535.983113.04
Adjustment below Net Profit 1.08-5.26-1.698.281.69-6.42
P & L Balance brought forward20090.4018348.8716660.0815864.1414671.4111799.30
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 232.300.00263.66439.45263.67234.38
P & L Balance carried down22273.9820090.4018348.8716660.0815864.1414671.41
Dividend232.300.00263.66439.450.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %400.000.00450.00750.00900.00400.00
Dividend Per Share(Rs)4.000.004.507.509.004.00
Earnings Per Share-Unit Curr41.5830.0833.3520.9424.8353.13
Earnings Per Share(Adj)-Unit Curr41.5830.0833.3520.9424.8353.13
Book Value-Unit Curr391.14353.55336.62307.80292.15271.80
Book Value(Adj)-Unit Curr391.14353.55336.62307.80292.15271.80
Top

Attention Investor:

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.